I-Mab Biopharma
IMAB
#9469
Rank
โ‚ฌ50.55 M
Marketcap
0,62ย โ‚ฌ
Share price
-6.87%
Change (1 day)
-63.23%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ13.49 Million

According to I-Mab Biopharma's latest financial reports the company's total liabilities are โ‚ฌ13.49 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ16.15 M-29.15%
2022-12-31โ‚ฌ22.8 M0.68%
2021-12-31โ‚ฌ22.64 M67.96%
2020-12-31โ‚ฌ13.48 M-80.43%
2019-12-31โ‚ฌ68.89 M11.94%
2018-12-31โ‚ฌ61.54 M136.7%
2017-12-31โ‚ฌ26 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ11.08 M-17.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.76 B 5,540.68%๐Ÿ‡บ๐Ÿ‡ธ USA